Position in LFCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,926
-$8,486 QoQ
Shares Held
518
-59.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LFCR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ROYAL BANK OF CANADA holds $672,203,105 across 64 Drug Manufacturers - Specialty & Generic names. LFCR ranks #47 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,974,284 | $233,380,104 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
9,984,082 | $138,279,533 | |
| 3 | BHC |
Bausch Health Companies Inc.
|
11,363,498 | $61,362,887 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
332,300 | $43,777,199 | |
| 5 | VTRS |
Viatris Inc
|
2,907,645 | $39,282,278 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
59,152 | $35,075,949 | |
| 7 | HLN |
Haleon plc
|
3,063,916 | $30,669,795 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
963,824 | $29,030,375 |
All Filings in LFCR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,926 | 518 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,412 | 1,273 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $905,257 | 122,997 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,009,720 | 124,350 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $123,164 | 17,495 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $242,559 | 32,646 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,833 | 3,009 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $10,280 | 2,004 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $674,370 | 127,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $655,563 | 105,907 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $933,119 | 123,592 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,421,499 | 147,001 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $561,204 | 148,467 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $976,502 | 150,695 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,309,665 | 147,319 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,467,074 | 147,149 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,198,622 | 103,508 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,191,273 | 107,322 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $968,614 | 105,056 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,024,896 | 91,102 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $878,771 | 82,903 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $569,342 | 52,474 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $388,994 | 40,020 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $509 | 64 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||